Regenxbio Inc banner

Wall St Price Targets

RB0 Price Forecast
Based on 14 analysts

+325% Upside
from €6.642 today

Regenxbio Inc (RB0)’s 12-month stock price forecast through November 2027 has a consensus target of €28.261, implying 325% upside. The forecast is based on price targets from 14 Wall Street analysts.

RB0 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for RB0 yet.

Regenxbio Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RB0's stock price target?
Price Target
28.261 EUR

According to Wall Street analysts, the average 1-year price target for RB0 is 28.261 EUR with a low forecast of 15.991 EUR and a high forecast of 69.266 EUR.

What is the Revenue forecast for Regenxbio Inc?
Projected CAGR
29%

Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 29%.

What is the Gross Profit forecast for Regenxbio Inc?
Projected CAGR
28%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 28%.

Back to Top